Originally published In Press as doi:10.1074/jbc.M004191200 on August 7, 2000
J. Biol. Chem., Vol. 275, Issue 43, 33252-33259, October 27, 2000
WbpO, a UDP-N-acetyl-D-galactosamine
Dehydrogenase from Pseudomonas aeruginosa Serotype O6*
Xin
Zhao
,
Carole
Creuzenet
§,
Myriam
Bélanger
§¶,
Emmanuel
Egbosimba
,
Jianjun
Li**, and
Joseph S.
Lam

From the
Department of Microbiology, University of
Guelph, Guelph, Ontario N1G 2W1 and the ** Institute for Biological
Sciences, National Research Council,
Ottawa, Ontario K1A OR6, Canada
Received for publication, May 16, 2000, and in revised form, July 18, 2000
 |
ABSTRACT |
WbpO is associated with B-band lipopolysaccharide
biosynthesis in Pseudomonas aeruginosa serotype O6. This
protein is thought to catalyze the enzymatic conversion of
UDP-N-acetyl-D-galactosamine (UDP-GalNAc) to
UDP-N-acetyl-D-galactosaminuronic acid
(UDP-GalNAcA). WbpO was overexpressed with a C-terminal hexahistidine
tag. The soluble form of expressed WbpO (WbpOSol) exhibited
a secondary structure with 29.2%
-helix and 20.1%
-strand.
However, no enzymatic activity could be detected using either high
performance anion exchange chromatography or capillary
electrophoresis-mass spectrometry analysis. An insoluble form of
expressed WbpO was purified in the presence of guanidine hydrochloride
by immobilized metal ion affinity chromatography. After refolding, this
preparation of WbpO (designated as WbpORf) exhibited stable
secondary structure at pH 7.5 to 8.2, and it was enzymatically active.
Capillary electrophoresis-mass spectrometry and tandem mass
spectrometry analysis showed that WbpORf catalyzed the
conversion of UDP-GalNAc to UDP-GalNAcA. 26 and 22% of the substrate
could be converted to UDP-GalNAcA in the presence of NAD+
and NADP+ as the cofactors, respectively. The
Km values of WbpORf for UDP-GalNAc,
NAD+, and NADP+ were 7.79, 0.65, and 0.44 mM, respectively. WbpORf can also catalyze the
conversion of UDP-GlcNAc to UDP-GlcNAcA. In conclusion, this is the
first report of the overexpression, purification, and biochemical characterization of an
NAD+/NADP+-dependent UDP-GalNAc
dehydrogenase. Our results also complete the biosynthetic pathway for
GalNAcA that is part of the O-antigen of P. aeruginosa
serotype O6 lipopolysaccharide.
 |
INTRODUCTION |
Pseudomonas aeruginosa is an opportunistic bacterial
pathogen that poses a threat to compromised individuals including those with cystic fibrosis, trauma, and burn wounds (1). Lipopolysaccharide (LPS)1 is one of many
virulence factors involved in the pathogenesis of P. aeruginosa, and it is also implicated as the surface antigen interacting with cystic fibrosis transmembrane regulator protein on
epithelial cells of healthy individuals (2). P. aeruginosa produces simultaneously two forms of LPS, designated A-band and B-band
(3). A-band LPS is a common antigen and is composed of trisaccharide
repeating units of
-D-rhamnose. B-band LPS O-antigen is
serotype-specific. It is composed of a heteropolymer of di- to
pentasaccharide repeating units. Due to its importance in virulence and
its potential as a vaccine component, LPS in P. aeruginosa has been extensively studied at the molecular level (4).
The International Antigenic Typing Scheme serotype O6 is the most
clinically prevalent serotype among all P. aeruginosa
strains (5-7). Its B-band O-antigen is a repeating linear
tetrasaccharide containing
-L-rhamnose,
N-acetyl-
-D-2,6-dideoxy-glucosamine (N-acetyl-
-D-quinovosamine), and two
-D-galactosaminuronic acid residues, one of which is
formylated and the other acetylated (GalNAcA) (8, 9). Structural
analysis of polysaccharides with mass spectrometry, high performance
liquid chromatography (10), and NMR (11-16) has indicated that
-D-GalNAcA is one of the most common acidic sugars
identified in the O-antigens or capsular polysaccharides of virulent
Gram-negative bacteria. Reddy et al. (11) suggested that
bacterial capsules and LPS containing acidic sugar repeats play an
important part in bacteria and host cells interactions. Examples of
-D-GalNAcA containing polysaccharides among bacteria
include the following: O-antigen polysaccharide of P. aeruginosa serotype O6 (4), Pseudomonas
solanacearum (12), Pseudomonas fluorescens biovar B
(17), Shigella-like Escherichia coli O121 (16),
Acinetobacter sps. (13), and Vibrio anguillarum
(12); as well as capsular polysaccharide of Salmonella typhi
(18), Staphylococcus aureus (19), and Vibrio
vulnificus (11, 15). Although the genes that are involved in the
biosynthesis of
-D-GalNAcA have been described in a few
studies (1, 18, 19), the enzyme activities of these gene products have
not been elucidated. At present UDP-GalNAcA is not commercially
available; therefore, a better understanding of the enzyme involved in
the synthesis of this uronic acid sugar would provide the methodology for its production.
The sequencing and characterization of the complete cluster of
wbp genes involved in the biosynthesis of P. aeruginosa serotype O6 LPS has recently been accomplished by our
laboratory (20). Based on homology analysis, one of the genes of the O6
LPS biosynthetic cluster, wbpO, was thought to be an enzyme
involved in the synthesis of
-D-GalNAcA. Importantly, a
knockout mutant of wbpO is deficient in B-band LPS
production (20). Furthermore, WbpO has significant homology to VipA
(64% identity), an enzyme presumed to be involved in the formation of
D-GalNAcA molecule of Vi-antigen in S. typhi (18). A wbpO mutant was successfully complemented by
vipA, and the production of B-band LPS of P. aeruginosa O6 was fully restored (20). This indicated that WbpO
and VipA are functional homologues of each other. These observations
suggested that WbpO could be a
UDP-N-acetyl-D-galactosamine (UDP-GalNAc)
dehydrogenase that catalyzes the conversion of UDP-GalNAc to
UDP-GalNAcA, which may be an intermediate in the synthesis of the
-D-GalNAcA moiety of the B-band O-unit in serotype O6.
This study is the first report of the expression, purification, and
function identification of an enzyme, WbpO, involved in the synthesis
of UDP-GalNAcA.
 |
EXPERIMENTAL PROCEDURES |
Sequence Analysis--
Amino acid homology analysis of WbpO was
accomplished by using Basic Local Alignment Search Tool (BLAST) through
data base Non-redundant GenBankTM CDS (21). Protein motif
analysis was performed by using the San Diego Supercomputer
Center-Multiple EM for Motif Elicitation data base via the.
Construction of WbpO with a C-terminal His6 Tag and
Sequencing--
wbpO was amplified by polymerase chain
reaction with the following primers. The upstream primer was 5'-TTT GTT
ACA TAT GAA GGA TCT GAA GGT TGC A-3', and the downstream primer was
5'-TAT TAC TCG AGA GAC AGG CGT AGA TCA GAC-3',
which contained NdeI and XhoI restriction sites,
respectively. The downstream primer also contained the indicated
mutation sites to change the original stop codon TAA to TCT coding
serine. This polymerase chain reaction product was cloned into the
NdeI and XhoI sites of pET30a expression vector
(Novagen, Madison, WI) and the sequence encoding His6 tag on pET30a was in frame with wbpO. This construct was
transformed into E. coli JM109 by CaCl2
transformation (22). Transformants were selected on Luria agar (Fisher)
containing 30 µg·ml
1 kanamycin. Both
strands of DNA were sequenced to confirm the sequence of the cloned
wbpO.
Overexpression of the Plasmid-encoded WbpO--
E.
coli BL21(DE3)pLysS strain (Novagen, Madison) was used to express
WbpO. It was grown overnight at 37 °C in Terrific Broth (TB) (23)
medium containing 30 µg·ml
1 kanamycin and
34 µg·ml
1 chloramphenicol with agitation
and then inoculated at 2% (v/v) into 300 ml of fresh TB medium and
grown at 37 °C to an A600 of 0.6. Overexpression of the recombinant WbpO was induced with 1 mM isopropyl-
-O-thiogalactopyranoside (IPTG)
for 3.5 h. The cells were harvested by centrifugation at
6,000 × g for 10 min, and the cell pellet was stored
at
20 °C.
Protein Concentration--
Protein concentration was determined
by the BCA method (24) following the procedure described by the
manufacturer (Pierce), and bovine serum albumin was used as the standard.
WbpO Purification and Refolding--
Frozen cell pellet (0.4 g,
wet weight) was suspended in 20 ml of suspension buffer (20 mM Tris-HCl and 0.5 M NaCl, pH 8) and sonicated
on ice for 2 min with Sonicator Ultrasonic Processor XL 2020 (MANDEL
Scientific Company Ltd., Guelph, Ontario, Canada). The cell extract was
centrifuged at 10,000 × g for 20 min.
The pellet containing the insoluble WbpO was dissolved in 5 ml of
suspension buffer with the addition of 6 M guanidine HCl (GdnHCl) and 5 mM imidazole. It was purified by immobilized
metal ion affinity chromatography (IMAC) on a chelating Sepharose Fast Flow resin (Amersham Pharmacia Biotech) using nickel as a chelating agent, which has high selective binding for proteins with
His6 tags, under denaturing conditions. The resin was first
charged with 50 mM NiSO4 and then equilibrated
with loading buffer (6 M GdnHCl, 5 mM imidazole
in 10 mM Tris-HCl, pH 8). Crude WbpO in 6 M
GdnHCl was loaded 3 times onto a 1.6-cm diameter column containing 3 ml
of resin. The column was first washed with 20 bed volumes of loading
buffer and then 4 bed volumes of 20 mM imidazole in loading
buffer. WbpO was eventually eluted with 4 bed volumes of 200 mM imidazole in loading buffer and subjected to refolding.
The refolding of WbpO began with reducing GdnHCl concentration from 6 to 2 M by dilution with 20 mM Tris-HCl, pH 8.0, at a rate of 0.5 ml·min
1. At the completion
of this step, 5 mM reduced and 1 mM oxidized glutathione were added. A protease inhibitor mixture that contains 4-(2-aminoethyl)benzenesulfonyl fluoride, bestatin, pepstatin A,
trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane,
and
N-(
-rhamnopyranosyloxyhydroxyphosphiny)-Leu-Trp(phosphoramidon) was added. The protein solution was then slowly stirred at 4 °C for
30 h to allow refolding, followed by slow dilution at an extremely low rate of 0.2 ml·min
1 and concentration
with ultrafiltration. Ultrafiltration was performed under 50 pounds/square inch N2 in a stir cell with YM3 membrane (Amicon, Sunnyvale, CA) which has a molecular mass cut-off at 3,000 Da. GdnHCl was finally removed by extensive dialysis against 200 volumes of 20 mM Tris-HCl, pH 8.0, with 3 buffer changes. All the purification and refolding procedures were performed between pH
7.5 and 8.0, which is well above the pI 5.8 of WbpO to minimize protein
precipitation. Any precipitate observed during the refolding and
dilution steps was removed by filtration through a 0.2-µm filter.
The supernatant of the cell extract containing the soluble WbpO
(WbpOSol) was subjected to purification under native
conditions, which was carried out under the same conditions as the
purification under denatured condition except that no GdnHCl was
present. WbpOsol was eluted with 40-120 mM
imidazole and then dialyzed against 20 mM Tris-HCl, pH
8.0.
Protein Analysis--
The protein fraction in 6 M
GdnHCl eluted from IMAC column was diluted to 1 M GdnHCl
and precipitated with trichloroacetic acid for analysis with 10%
SDS-polyacrylamide gel electrophoresis (25). Western immunoblotting
following SDS-polyacrylamide gel electrophoresis was performed
according to Burnette (26) using Penta-HisTM Antibody
(Qiagen, Mississauga, Ontario, Canada) diluted to 1:1,000 in 3% bovine
serum albumin in Tris-buffered saline as the first antibody.
CD Spectrometry--
CD of WbpO protein was measured with a
JASCO J-600 spectropolarimeter (Japan Spectroscopic Co. Ltd., Tokyo,
Japan) at 20 °C. Secondary structure fractions were tabulated using
the JASCO Protein Secondary Structure Estimation Program (Japan
Spectroscopic Co., Tokyo, Japan) which is based on the algorithm of
Chang et al. (27), and our results were analyzed using the
data base of Hennessey and Johnson (28). Spectra were recorded between
190 and 250 nm, and three spectra of each sample were obtained and
their values averaged. All protein samples were adjusted to 0.3 mg·ml
1 in 10 mM potassium
phosphate buffer, pH 8.0, and were degassed before scanning. The base
line was also corrected with 10 mM potassium phosphate
buffer. Measurements were performed with a cell path length of 1 mm.
Molar ellipticity was expressed in units of degree × cm2 × dmol
1 of amino acid
residues. The secondary structure of WbpO based on its amino acid
sequence was predicted using data base PredictProtein (29).
Enzyme Reaction and HPAEC--
The enzyme reaction mixture
contained 1.0 mM UDP-GalNAc, 2.5 mM
-nicotinamide adenine dinucleotide (NAD+), or
-nicotinamide adenine dinucleotide phosphate (NADP+), 5 mM MgCl2, and 10 mM Tris-HCl
buffer, pH 8.2, in a total volume of 0.1 ml. The reaction was initiated
by addition of purified WbpO solution, then incubated at 37 °C for
1 h, quenched by boiling for 10 min, and stored at
20 °C for
product analysis. Enzyme reaction was monitored by recording the
absorbance of the solution at 340 nm which indicates NAD(P)H
production. Sugar compositional analysis was performed by high
performance anion exchange liquid chromatography (HPAEC) equipped with
a pulsed amperometric detector on a Waters 625 LC system (Millipore,
Milford, MA). Sugars were separated on a CarboPac PA1 anion exchange
column (4 × 250 mm, Dionex, Sunnyvale, CA) equipped with a PA1
guard column, at a flow rate of 1.0 ml·min
1. Neutral and amino sugars were
separated with 14 mM NaOH in the initial 10 min. Acidic
sugars were then eluted by an application of a linear salt gradient up
to 100 mM NaOH and 150 mM NaOAc within 10 min.
The column was maintained in these conditions for 5 min and then washed
with 150 mM NaOH for 5 min before being re-equilibrated with 14 mM NaOH for 20 min.
The conversion ratio of UDP-GalNAc to UDP-GalNAcA was estimated based
on the comparison of peak areas under substrate and product,
respectively, from HPAEC.
Capillary Electrophoresis-Electrospray Mass Spectrometry (CE-MS)
and Tandem Mass Spectrometry (MS/MS)--
Sugar analysis by CE-MS or
CE-MS/MS was performed using a crystal model 310 CE instrument (AYI
Unicam, Boston) coupled to an API 3000 mass spectrometer (PerkinElmer
Life Sciences) via a micro-ion spray interface. The fused silica
capillaries used were 192 (outer diameter) × 50 µm (inner
diameter) (Polymicro Technologies, Phoenix, AZ). The separations were
obtained on a 90-cm long capillary using 50 mM
morpholine/formate, 5% methanol, pH 9.0, and a voltage of 30 kV was
applied. Collision-induced dissociation of selected precursor ions was
achieved using nitrogen as collision gas at collision energies of
typically 60-70 eV.
Kinetic Characterization of WbpORf--
The enzyme
reaction was performed at room temperature in 10 mM
ammonium acetate, pH 8.5, with a total volume of 100 µl containing sugar (UDP-GalNAc or UDP-GlcNAc), NAD(P)+,
WbpORf (0.1-12 µg), and 2 mM dithiothreitol.
The Km and Vmax values of
WbpORf were determined based on Michaelis-Menten equations,
and the sugar concentrations added ranged from 2 to 40 mM,
and the cofactor concentrations ranged from 0.2 to 5 mM. The enzyme reaction is monitored by following the reduction of NAD+ at 340 nm using spectrophotometer (DU® Series 520 spectrophotometer, Beckman Instruments, Mississauga, Ontario, Canada),
and the initial velocities were measured during the first 30 s
after the initiation of the reaction with NAD(P)+. NAD(P)H
concentrations were determined using the absorbance at 340 nm with
340 = 6,220 M
1·cm
1.
Determination of Cofactor Specificity--
For the determination
of the Km value for the cofactors, an excess amount
of sugar (40 mM) was used, and the cofactor concentrations
ranged from 0.1 to 5 mM.
Determination of Substrate Specificity of
WbpORf--
UDP-GalNAc, UDP-GlcNAc, and UDP-Gal were used
as the substrate, respectively, for the determination of the
specificity of WbpORf, and the reactions were carried out
in the presence of 5 mM NAD+. The enzyme
reactions using UDP-GalNAc or UDP-GlcNAc were analyzed by CE-MS/MS to
identify the product.
Requirement of Cations for the Enzyme Activity--
Enzyme
reactions containing 10 mM final concentration of
MgCl2, MnCl2, or KCl in addition to 6 mM UDP-GalNAc, 10 mM NAD+, 2 mM dithiothreitol, and 2.4 µg of enzyme were monitored at 340 nm for 30 min at room temperature.
 |
RESULTS |
Sequence Analysis--
Comparison of the sequence of WbpO
(GenBankTM accession number AF 035937) with other proteins
in the GenBankTM data base indicated that WbpO has high
homology to VipA (64% identity) and CapL (57% identity). VipA is
involved in the biosynthesis of S. typhi Vi-antigen, a
homopolymer polysaccharide consisting of GalNAcA (18, 30), and CapL is
thought to be involved in the biosynthesis of the same sugar of the
capsular polysaccharide in S. aureus (18). WbpO showed
moderate homology with EpsD, a putative NDP-GalNAcA dehydrogenase in
Burkholderia solanacearum, with an identity of 29% (31). It
also demonstrated homology with putative UDP-ManNAcA dehydrogenases in
Methanobacterium thermoautotrophicum (B7, 32% identity)
(32), Pyrococcus horikoshii (B8, 31% identity) (33),
Methanococcus jannaschii (Y428, 30% identity) (34), and
E. coli (35), respectively. Four conserved motifs located at
the N terminus of these sequences (Fig.
1) were found using San Diego
Supercomputer Center/Multiple EM for motif elicitation alignment tool.
These motifs also coincide with the conserved secondary structures.
Motif-1 contains a GXGXXG consensus (where X represents any amino acid and G represents glycine) in a


secondary structure, indicating the possible involvement of
nucleotide (i.e. NAD+ or NADP+) in
the WbpO function. Part of Motif-2 is in
-strand structure conformation, whereas the whole Motif-3 containing 27 amino acids is in
-helical structure. However, Motif-2, -3, and -4 do not correspond
to any known functional signature. These alignment results clearly
suggest that WbpO could be an enzyme involved in the formation of
uronic acid in polysaccharide biosynthesis. Furthermore,
complementation data previously obtained by our laboratory demonstrated
that the knockout mutant of WbpO could be cross-complemented by VipA
from S. typhi to restore the production of B-band LPS in O6
(20). All the above evidence led to the assignment of the function of
WbpO as a putative UDP-GalNAc dehydrogenase that produces
UDP-GalNAcA.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1.
Alignment of WbpO. Alignment with VipA
(Vi-antigen biosynthesis protein in S. typhi, accession
number sp Q04972), CapL (capsular biosynthesis protein in S. aureus, accession number sp P39861), EpsD
(NDP-N-acetyl-D-galactosaminuronic acid
dehydrogenase in B. solanacearum, accession number sp
Q45410), and UDP-N-acetyl-D-mannosaminuronic
acid dehydrogenase in M. thermoautotrophicum: B7 (accession
number gi 2621926), in P. horikoshii: B8 (accession number
gnl PID d1031673), in M. jannaschii: Y428 (accession number
sp Q57871), in E. coli: WecC (accession number sp P27829).
Positions of amino acids are indicated by the numbers flanking the
sequences. ID, identity to WbpO sequence.
|
|
Overexpression of WbpO--
WbpO was overexpressed by induction
with 1 mM IPTG in TB medium (Fig.
2A, lane 4). Results from
Western immunoblotting with Penta-HisTM Antibody showed a
band corresponding to 46 kDa (Fig. 2B) indicating that the
His6 tag was expressed as part of WbpO. A limited amount of
WbpO was also present in the non-induced culture (Fig. 2B, lane 3). Solubility analysis (data not shown) on the
expressed protein showed that approximately 90% of the expressed WbpO
was found in the cell debris fraction.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 2.
Overexpression, purification, and refolding
of recombinant WbpO. Protein samples were loaded onto 10%
SDS-polyacrylamide gel electrophoresis, and identified by Coomassie
Blue R-250 staining (A) and Western immunoblot with
Penta-HisTM Antibody (B). Lane 1, molecular mass
marker proteins. Lane 2, vector pET30a without
wbpO insert. Lanes 3 and 4,
overexpression of WbpO before (lane 3) and after (lane
4) induction with 1 mM IPTG. Lane 5, inclusion body proteins from E. coli BL21 (DE3)pLysS cells
expressing WbpO. Lane 6, IMAC purification of protein in
lane 5. Lane 7, refolded WbpO. Lane 8, soluble fraction of expressed proteins from E. coli cell
expression WbpO. Lane 9, IMAC purification of protein of
lane 8.
|
|
Purification and Refolding of WbpO--
The purification of
soluble form of WbpO by IMAC under native conditions yielded >95%
pure WbpO (Fig. 2A, lane 6), and the same purity
of WbpO was also achieved by the purification of the insoluble form
with IMAC under denaturing conditions (Fig. 2A, lane 9).
Effective refolding of WbpO required optimization of the ratios of
reduced and oxidized glutathione. The final concentrations of 5 and 1 mM of reduced and oxidized glutathione, respectively, were
deemed optimal for achieving the highest yield of 2 mg·g
1 cell pellet of WbpO with
approximately 99% purity (Fig. 2A, lane 7).
CD Analysis of WbpO--
The CD spectrum of WbpOSol
showed a minimum at 208 nm and a shoulder at 220 nm (Fig.
3), which are the characteristics of proteins that have an
-helical conformation (36-38). The CD
spectrum of refolded WbpO (WbpORf) showed different
patterns and weaker ellipticities than that of WbpOSol.
This suggests a lower percentage of
-helical structure than in
WbpOSol, and these results are consistent with the
calculations, 29.2% for WbpOsol and 22.0% for
WbpORf, respectively, as shown in Table
I. WbpORf also showed altered
CD spectrum with a minimum circular dichroism signal at 198 nm, which
indicated an increased content of
-turn in the secondary structure
(39, 40).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
CD spectra of WbpOSol at pH 8.2 and WbpORf prepared at pH 5.5, 6.5, 7.5, and 8.2. Each
spectrum represents an average of three scans recorded at room
temperature in a cell of 1-mm path length. All proteins had
concentrations of 0.3 mg ml 1 in 10 mM potassium phosphate buffer.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Secondary structure calculations from CD analysis on WbpOSol
and WbpORf and the effect of pH on the secondary structure of
WbpORf
|
|
CD spectra were recorded with WbpORf, which had been
dialyzed to pH 8.2, 7.5, 6.5, and 5.5, respectively. As the pH
decreased, the CD spectra were shifted toward the UV region suggesting
an increased percentage of turns in the secondary structure of the protein. In particular, the CD spectrum of WbpORf at pH 5.5 demonstrated high proportions of turns and coils with much less
-helices (10.9%) and
-strands (12.1%) (Table I). Since WbpO has
a predicted pI of 5.8, we suspect that the loss of secondary structure
at pH 5.5 corresponds to isoelectric precipitation of the protein.
These observations also showed that the secondary structure of
WbpORf was relatively stable in the range of pH 7.5-8.2.
Consequently, a pH between 8 and 8.2 was chosen to carry out enzymatic reactions.
Enzyme Reaction and HPAEC Analysis--
To assess the enzymatic
activity of WbpO, HPAEC was used to analyze the product of the typical
enzyme reaction. Neither NAD(P)+ nor UDP-GalNAc would bind
on the column, and these compounds were eluted during the first 10-min
wash with 14 mM NaOH with only a slight separation. When
the reaction with WbpORf was analyzed by HPAEC, a new peak
was observed after 8.49 min elution with the salt gradient (Fig.
4). Uronic acids are known to bind to the
CarboPac PA1 column in our operating conditions and elute with NaOAc
gradient (41). Hence the new peak that we observed is consistent with
uronic acid formation, and it was collected for further CE-MS/MS
analysis to determine its identity. HPAEC analysis also indicated the
requirement of NAD(P)+ for the catalysis to occur. In
contrast to WbpORf, WbpOSol did not show any
detectable enzyme activity. Moreover, precipitation of a small amount
of WbpOSol was observed during the 1-h incubation of the
enzyme assay, whereas refolded WbpORf was stable in the reaction mixture.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 4.
HPAEC analysis of the product of
WbpORf enzymatic reaction using UDP-GalNAc.
Separations were performed on an analytical column of CarboPac PA1
(Dionex Corp.) by using 14 mM NaOH for 10 min and applying
100 mM NaOH, 150 mM NaOAc gradient in 10 min
and maintaining in this condition for 5 min.
|
|
CE-MS/MS--
To identify the product of the enzyme reaction of
WbpO, CE-MS analysis was performed on the collected peak from HPAEC as
well as the whole enzymatic reaction of WbpO. An ion peak at
m/z 620.0, which is consistent with the mass of the expected
product UDP-GalNAcA (m/z 621, Fig.
5), was observed in both samples. The
substrate (UDP-GalNAc) peak at m/z 605.0 was also observed
in the CE/MS on the whole enzyme reaction. Both of the product
(m/z 620.0) and substrate (m/z 605.0) were
further analyzed by MS/MS.
MS/MS analysis of the product peak m/z 620.0 is shown in
Fig. 6, and the fragments corresponding
to each peak are depicted in Table II. In
addition to the parent peak at m/z 620.0, other peaks at
m/z 174.5, 254.5, 506.0, 522.0, and 540.0 were observed and
matched to the fragments of GalA-O, GalNA-PO3,
GalNAcA-PO3-PO3-Rib, GalNAcA-PO3-PO3-Rib-NH, and
GalNAcA-PO3-PO3-Rib-NH2=CH2,
respectively (Table II). These six fragments exhibited diagnostic
signature for the existence of the carboxyl group attached to the Gal
ring. It also indicated the attachment of GalNAcA to the phosphate
moiety of UDP.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
CE-MS/MS analysis for selected precursor ions
of m/z 620.0 from the product of WbpORf
enzymatic reaction.
|
|
Two other fragments corresponding to m/z 408.0 for
Gal-PO3-PO3-Rib and m/z 426.0 for
GalN-PO3-PO3-Rib that did not contain carboxyl
group provided further evidence to indicate the attachment of the
carboxyl group to the Gal ring rather than to other moieties.
The ion peaks at m/z 78.5 (PO3) and
m/z 158.5 (PO3-PO3) provided
evidence for the existence of a diphosphate moiety. The appearance of
another three peaks at m/z 133.5 for PO2-Rib,
m/z 272.5 for PO2-PO3-Rib, and
m/z 290.5 for PO3-PO3-Rib further
suggested the attachment of the diphosphate moiety to the ribose ring
as a part of UDP. By comparing to the MS/MS results of the substrate
UDP-GalNAc (m/z 605.0, data not shown), the ion peak at
m/z 620.0 is identified to correspond to UDP-GalNAcA.
In addition to the m/z 620.0 peak, two additional new peaks
at m/z 565.0 and 575.0 (data not shown) were observed in the
CE/MS analysis of both collected peak from HPAEC and the whole WbpO enzymatic reaction. Further MS/MS analysis had identified them to be
the breakdown fragments of the product UDP-GalNAcA by losing acetylamino and acetyl groups, respectively.
Physicokinetic Characterization of WbpORf--
The
production of the product UDP-GalNAcA or NAD(P)H was linear over time
within the initial 10 min of the enzyme reaction and reached a maximum
after 30 min. The enzyme activity is relatively constant over a wide
temperature range from 37 to 56 °C, and the optimum pH is 8.5.
Kinetic Characterization of WbpORf--
The
measurement of the initial velocities for the calculation of kinetic
parameters was performed by using different dilutions of the enzyme to
ensure less than 10% conversion of the substrate within the initial
30 s. The kinetics of the enzyme reaction of WbpORf
followed the Michaelis-Menten model. The Km values of WbpORf derived from the double-reciprocal plots are 7.89 for UDP-GalNAc and 0.65 and 0.44 mM for NAD+
and NADP+, respectively (Table
III).
Substrate Specificity of
WbpORf--
WbpORf can also use UDP-GlcNAc as
the substrate, and the product of this enzyme reaction was identified
as UDP-GlcNAcA by CE-MS/MS (data not shown). The Km
value for UDP-GlcNAc using NAD+ was 22.2 mM.
WbpORf showed very low activity using UDP-Gal as the
substrate. In this reaction, despite using 5 times more enzyme, the
conversion of the cofactor NAD+ within 30 min is less than
10% compared to that using UDP-GalNAc as the substrate (data not shown).
Requirement of Cations for the Enzyme Activity and Enzyme
Stability--
The enzymatic reactions of WbpORf in the
presence of MgCl2, MnCl2, or KCl were also
recorded within the initial 30 min. In the presence of 10 mM MgCl2 or MnCl2, there was
approximately 9% increase in NADH generation, whereas KCl did not have
any effect on the enzyme reaction (data not shown).
In terms of shelf life, the enzyme retained
80% activity after being
preserved in 25% glycerol or 20% adonitol for 2 weeks at
20 °C.
 |
DISCUSSION |
All proteins shown in Fig. 1 possess a NAD(P)+ binding
domain (Motif-1) that is composed of about 30 amino acids with a
predicted secondary structure of 

(18, 42). This domain is
highly conserved among NAD(P)+-dependent
dehydrogenases (18, 43). Therefore, the sequence conservation observed
in Motif-2 and Motif-3 also coincides with structure conservation since
Motif-2 and Motif-3 are in
-strand and
-helix conformation,
respectively, in WbpO. The identification of the NAD(P)+
binding domain and amino acid sequence homology and gene
complementation data strongly suggest that WbpO is a
NAD(P)+-dependent dehydrogenase. Since all the
conserved motifs in WbpO were close to the N terminus of the sequence,
a His6 tag was added at the C terminus of WbpO to
facilitate its purification and identification.
The small amount of WbpO expressed before the induction with IPTG was
likely due to a leaky expression of the wbpO-pET30a vector
by the host (lane 3, Fig. 2, A and B).
Since all experiments were performed at pH 8 well above the pI (5.8) of
WbpO, the observed instability of purified WbpOSol might be
due to the incorrect folding of the protein during expression rather
than isoelectric precipitation. Since we observed >90% of the
expressed WbpO in an insoluble form and the WbpOSol was
unstable in solutions, the refolding experiment was a worthwhile task
for characterizing the enzyme activity of WbpO.
By optimizing the refolding conditions such as adjusting the reduced to
oxidized glutathione ratios, most of the contaminating proteins could
be precipitated and were subsequently removed by filtration. Moreover,
to obtain a properly refolded protein, the use of low protein
concentration, i.e. <0.1
mg·ml
1, is necessary to avoid any
intermolecular disulfide bond formation (44) during the refolding
procedure. Unlike the fast process in vivo, in
vitro disulfide bond formation is an extremely slow reaction
and could take hours to days (45). In our case, refolding of WbpO was
optimal at approximately 30 h. It is also important to perform
dilution and concentration steps slowly to minimize the precipitation
of the target protein. Other refolding procedures, which involved
sequential dialysis with decreased concentrations of urea (46, 47)
followed by renaturation of the protein immobilized to affinity resin
(48) and renaturation of protein in 20% glycerol (49), generally
result in very low yields because of protein precipitation problems.
The procedure described in this paper provided an optimal condition to
achieve high purity and high yield of WbpO with tight secondary structure.
The proportion of
-helices observed in both WbpOSol
(29.2%) and WbpORf (22.0% at pH 8.2) are lower than the
predicted value (38.3%) based on the amino acid sequence of WbpO,
whereas the
-strand contents of these two forms of WbpO (20.1 and
19.6%, respectively), are higher than the predicted value of 16.8%.
However, the total percentage (49.2%) of
- and
-structure of
WbpOSol is consistent with that of some other
dehydrogenases (48-51%) (50, 51). The differences between CD spectra
of WbpOSol and WbpORf reflect the differences
in the structures of these two forms of WbpO. In WbpORf the
total percentages of
-helix and
-strand are not as high as those
in WbpOSol and suggested that the secondary structure of
WbpORf was not as tight as that of WbpOSol.
Interestingly, the fact that WbpOSol has no detectable enzyme activity implied that it might have an incorrect secondary structure. This interpretation was substantiated by the observation that WbpOSol was prone to precipitation when being used in
an enzyme assay. Moreover, the gradual removal of GdnHCl during
refolding of WbpO may cause more disulfide bonds forming on the surface of the protein so that high negative ellipticities at 198 nm were observed on CD spectrum of WbpORf (39, 40).
Furthermore, the optimum pH of 8.2 for the enzymatic reaction of WbpO
is in good agreement with the highest secondary structure content at pH
8.2 from CD analysis.
In our HPAEC analysis, we observed a new peak eluted from NaOAc
gradient which is consistent with the results shown by previous studies
(41) that acidic sugars are eluted from CarboPac column in NaOAc
gradient. Since UDP-GalNAcA was not commercially available to be used
as a standard in the HPAEC, we had to performed CE-MS/MS to identify
the product (UDP-GalNAcA). Running the samples through CE prior to MS
analysis allowed further separation of the product and facilitated the
interpretation of the MS spectra.
From the MS/MS analysis, all the fragments related to the existence
(m/z 174.5, 254.5, 506.5, 522.0, and 620.0) and loss
(m/z 408.0 and 426.0) of the carboxyl group implied that the
galactose ring remained intact. These observations also indicate that
the only possible position of the carboxylation would be at C-6 of the
galactose moiety by replacing the -CH2OH in UDP-GalNAc
with -COOH. From the CE-MS/MS analysis on the enzyme reaction, some fragments such as m/z 565.0 and 575.0 were derived from the
product UDP-GalNAcA, whereas the substrate UDP-GalNAc at m/z
605.0 was fairly stable without any break-down fragments being
detected. This implied the N-acetyl group in UDP-GalNAcA is
not as stable as that in UDP-GalNAc.
In terms of a requirement for coenzyme, our results showed that
NAD(P)+ was required for the enzyme activity of WbpO. This
correlates well with the presence of the GXGXXG
as part of Motif-1 in WbpO and also with the previous studies on
chain-fold similarities of proteins that bind the cofactor
NAD+ (54) that the GXGXXG is a
fingerprint of NAD(P)+ binding domain. Our result of enzyme
reaction also showed that WbpORf was active with both
NAD+ and NAD(P)+ as the cofactor, which has
been observed with some other dehydrogenases (55, 56). In addition, as
shown by the kcat in our kinetic studies (Table
III), WbpORf does not have significant preference on using
NAD+ or NAD(P)+ as the cofactor.
Also from the kinetics investigation, WbpORf showed
approximately 3 times lower Km and 10 times higher
kcat toward UDP-GalNAc than that toward
UDP-GlcNAc, suggesting the preference of WbpORf to
UDP-GalNAc as the substrate. Moreover, the value of
kcat/Km, an indicator of the
binding efficiency of the sugar to its site on the enzyme, for
UDP-GalNAc is about 25 times higher than that for UDP-GlcNAc. This
further implies that the preference of WbpORf toward the
two sugars is due to the less efficient binding of UDP-GlcNAc to the
enzyme. In addition, the activity of WbpORf in the presence
of UDP-Gal, the non-N-acetylated form of UDP-GalNAc, was
very low. Therefore, WbpORf is specific for the
N-acetylated substrate, with a clear preference for
UDP-GalNAc over UDP-GlcNAc.
At present, UDP-GalNAcA is not commercially available. Thus the
findings from this study of WbpORf provided the means to
produce this acidic nucleotide sugar enzymatically and inexpensively. The substrate UDP-GalNAc is commercially available; however, it is very
expensive. We could circumvent this problem by using the enzymatic
conversion from UDP-GlcNAc to UDP-GalNAc with the C4 epimerase, WbpP (Fig. 7). A recent study
from our laboratory (57) showed that at equilibrium WbpP converts only
30% of UDP-GlcNAc to UDP-GalNAc. However, this low conversion could be
compensated by the sequential (or coupled) enzymatic reactions in the
presence of both WbpP and WbpO using only UDP-GlcNAc as the substrate. On the other hand, as indicated in Table III, the higher catalysis efficiency of WbpORf toward UDP-GalNAc than UDP-GlcNAc will
facilitate the production of UDP-GalNAcA with an anticipated low yield
of a by-product such as UDP-GlcNAcA. Moreover, WbpORf was
found to be relatively stable upon storage in the presence of 25%
glycerol or 20% adonitol and possesses a high specificity. Thus, the
protein is suitable for long term use once it has been prepared.
Therefore, the procedures described in this paper are suitable for
convenient preparation of UDP-GalNAcA.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 7.
Proposed biosynthetic pathway of UDP-GalNAcA
and its contribution to the tetrasaccharide repeat of the O-antigen of
P. aeruginosa serotype O6 LPS.
UDP-GlcNAc,
UDP-N-acetyl-D-glucosamine; GalNFmA,
N-formyl-D-galactosaminuronic acid;
GalNAcA,
N-acetyl-D-galactosaminuronic acid;
Rha, L-rhamnose; Wzx, flippase (67);
Wzy, O-antigen O-polymerase (66); Wzz,
O-antigen chain length regulator (3).
|
|
WbpORf can also be used to produce UDP-GlcNAcA from
UDP-GlcNAc. Although its Km value for UDP-GlcNAc is
higher than that reported for UDP-GlcNAc dehydrogenase purified from
Micrococcus luteus (58), WbpORf has the
advantage of being easier to be prepared in large amounts following the
overexpression and refolding procedures described in this study.
For the kinetics measurement of the enzyme, Tris-HCl buffer was shown
in a report by Trivic et al. (59) to affect the result of
kinetic constant that was measured based on the generation of
NAD(P)+ at 340 nm. Therefore, the enzyme reactions in this
study were performed in ammonium acetate buffer instead of Tris-HCl as
used for HPAEC and CE-MS/MS.
From investigations of the requirement of cations for the enzyme
reaction, our results showed that WbpORf does not require any cations for the reaction to occur, which is similar to the properties observed in other dehydrogenases. However, the presence of
Mg2+ or Mn2+ showed enhanced effect on the
enzyme activity of WbpORf. This is similar to the effect of
K+ on the enzymatic reaction of UDP-ManNAc dehydrogenase
(60).
Also as a comparison, the Km value of
WbpORf for UDP-GalNAc at 7.79 mM is within the
range of the reported values for UDP-Glc dehydrogenase (61, 62) and
glucose dehydrogenase (63, 64). However, this value is relatively high
when compared with those for UDP-GlcNAc dehydrogenase (0.28 mM, see Ref. 58) and UDP-ManNAc dehydrogenase (0.22 mM, see Ref. 60). The higher Km value of
WbpORf could be due to the fact that our kinetic parameters
were obtained with a refolded protein. As shown in the structural
analysis by CD, WbpORf showed less secondary structures
than of WbpO expressed in a soluble form.
As mentioned above, Creuzenet et al. (57) recently reported
the UDP-GlcNAc C4 epimerase function of WbpP, which
catalyzes the metabolic step that provides the substrate, UDP-GalNAc,
for WbpO. Thus, by achieving the enzymatic characterization of WbpO, our laboratory has verified the proposed two-step biosynthetic pathway
of UDP-GalNAcA (see Refs. 3, 20, 66, and 67, Fig. 7) which is the
precursor of one residue of the trisaccharide repeating unit of the
O-antigen in LPS of P. aeruginosa serotype O6.
To date, WbpO is the first UDP-GalNAc dehydrogenase that has been
characterized at the molecular and biochemical level. The results in
this study have provided significant biological and structural evidence
to establish the function of WbpO as a
NAD(P)+-dependent UDP-GalNAc dehydrogenase
(Fig. 5, see Ref. 65) that catalyzes Reaction 1.
 |
ACKNOWLEDGEMENT |
We are grateful to Dr. Warren Wakarchuk of the
Institute of Biological Sciences, National Research Council, Canada,
for the critical reading of this paper.
 |
FOOTNOTES |
*
This work was supported in part by Grant MT14796 (to
J. S. L.) from the Medical Research Council of Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipients of fellowships from the Canadian Cystic Fibrosis Foundation.
¶
Current address: Dept. of Pathobiology, College of Verterinary
Medicine, University of Florida, Gainesville, FL 32611-0880.
Recipient of the Canadian Commonwealth Scholarship.

To whom correspondence should be addressed: Dept.
of Microbiology, University of Guelph, Guelph, Ontario N1G 2W1, Canada. Tel.: 519-824-4120, ext. 3823; Fax: 519-837-1820; E-mail:
jlam@uoguelph.ca.
Published, JBC Papers in Press, August 7, 2000, DOI 10.1074/jbc.M004191200
 |
ABBREVIATIONS |
The abbreviations used are:
LPS, lipopolysaccharide;
HPAEC, high performance anion exchange
chromatography;
CE-MS, capillary electrophoresis-mass spectrometry;
MS-MS, tandem mass spectrometry;
IPTG, isopropyl-
-O-thiogalactopyranoside;
GdnHCl, guanidine
HCl;
UDP-GalNAcA, UDP-N-acetyl-D-galactosaminuronic acid;
IMAC, immobilized metal ion affinity chromatography.
 |
REFERENCES |
| 1.
|
Stanislavsky, E. S.,
and Lam, J. S.
(1997)
FEMS Microbiol. Rev.
21,
243-277
|
| 2.
|
Pier, G. B.,
Grout, M.,
Zaidi, T. S.,
Olsen, J. C.,
Johnson, L. G.,
Yankaskas, J. R.,
and Goldberg, J. B.
(1996)
Science
271,
64-67
|
| 3.
|
Burrows, L. L.,
Chow, D.,
and Lam, J. S.
(1997)
J. Bacteriol.
179,
1482-1489
|
| 4.
|
Rocchetta, H. L.,
Burrows, L. L.,
and Lam, J. S.
(1999)
Microbiol. Mol. Biol. Rev.
63,
523-553
|
| 5.
|
Bert, F.,
and Lambert-Zechovsky, N.
(1996)
J. Antimicrob. Chemother.
37,
809-813
|
| 6.
|
Vachee, A.,
Scheftel, J. M.,
Husson, M. O.,
Izard, D.,
Ross, P.,
and Monteil, H.
(1997)
Pathol. Biol.
45,
357-362
|
| 7.
|
Pitt, T. L.
(1988)
Eur. J. Clin. Microbiol. & Infect. Dis.
7,
238-247
|
| 8.
|
Knirel, Y. A.
(1990)
Crit. Rev. Microbiol.
17,
273-304
|
| 9.
|
Knirel, Y. A.,
Rietschel, E. T.,
Marre, R.,
and Zahringer, U.
(1994)
Eur. J. Biochem.
221,
239-245
|
| 10.
|
Kaya, S.,
Araki, Y.,
and Ito, E.
(1989)
J. Biochem. (Tokyo)
105,
35-38
|
| 11.
|
Reddy, G. P.,
Hayat, U.,
Bush, C. A.,
and Morris, J. G., Jr.
(1993)
Anal. Biochem.
214,
106-115
|
| 12.
|
Orgambide, G.,
Montrozier, H.,
Servin, P.,
Roussel, J.,
Trigalet-Demery, D.,
and Trigalet, A.
(1991)
J. Biol. Chem.
266,
8312-8321
|
| 13.
|
Haseley, S. R.,
Holst, O.,
and Brade, H.
(1997)
Eur. J. Biochem.
244,
761-766
|
| 14.
|
Knirel, Y. A.,
Kocharova, N. A.,
Shashkov, A. S.,
Kochetkov, N. K.,
Kholodkova, E. V.,
and Stanislavsky, E. S.
(1987)
Eur. J. Biochem.
166,
189-197
|
| 15.
|
Reddy, G. P.,
Hayat, U.,
Xu, Q.,
Reddy, K. V.,
Wang, Y.,
Chiu, K. W.,
Morris, J. G., Jr.,
and Bush, C. A.
(1998)
Eur. J. Biochem.
255,
279-288
|
| 16.
|
Parolis, H.,
Parolis, L. A.,
and Olivieri, G.
(1997)
Carbohydr. Res.
303,
319-325
|
| 17.
|
Shashkov, A. S.,
Paramonov, N. A.,
Veremeychenko, S. P.,
Grosskurth, H.,
Zdorovenko, G. M.,
Knirel, Y. A.,
and Kochetkov, N. K.
(1998)
Carbohydr. Res.
306,
297-303
|
| 18.
|
Hashimoto, Y.,
Li, N.,
Yokoyama, H.,
and Ezaki, T.
(1993)
J. Bacteriol.
175,
4456-4465
|
| 19.
|
Lin, W. S.,
Cunneen, T.,
and Lee, C. Y.
(1994)
J. Bacteriol.
176,
7005-7016
|
| 20.
|
Bélanger, M.,
Burrows, L. L.,
and Lam, J. S.
(1999)
Microbiology
145,
3505-3521
|
| 21.
|
Altschul, S. F.,
Madden, T. L.,
Schaffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402
|
| 22.
|
Huff, J. P.,
Grant, B. J.,
Penning, C. A.,
and Sullivan, K. F.
(1990)
BioTechniques
9,
570-577
|
| 23.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, p. A2, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 24.
|
Smith, P. K.,
Krohn, R. I.,
Hermanson, G. T.,
Mallia, A. K.,
Gartner, F. H.,
Provenzano, M. D.,
Fujimoto, E. K.,
Goeke, N. M.,
Olson, B. J.,
and Klenk, D. C.
(1985)
Anal. Biochem.
150,
76-85
|
| 25.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 26.
|
Burnette, W. N.
(1981)
Anal. Biochem.
112,
195-203
|
| 27.
|
Chang, C. T.,
Wu, C. S.,
and Yang, J. T.
(1978)
Anal. Biochem.
91,
13-31
|
| 28.
|
Hennessey, H. P., Jr.,
and Johnson, W. C., Jr.
(1981)
Biochemistry
20,
1085-1094
|
| 29.
|
Rost, B.
(1996)
Methods Enzymol.
266,
525-539
|
| 30.
|
Waxin, H.,
Virlogeux, I.,
Kolyva, S.,
and Popoff, M. Y.
(1993)
Res. Microbiol.
144,
363-371
|
| 31.
|
Huang, J.,
and Schell, M.
(1995)
Mol. Microbiol.
16,
977-989
|
| 32.
|
Smith, D. R.,
Doucette-Stamm, L. A.,
Deloughery, C.,
Lee, H.,
Dubois, J.,
Aldredge, T.,
Bashirzadeh, R.,
Blakely, D.,
Cook, R.,
Gilbert, K.,
Harrison, D.,
Hoang, L.,
Keagle, P.,
Lumm, W.,
Pothier, B.,
Qiu, D.,
Spadafora, R.,
Vicaire, R.,
Wang, Y.,
Wierzbowski, J.,
Gibson, R.,
Jiwani, N.,
Caruso, A.,
Bush, D.,
Safer, H.,
Patwell, D.,
Prabhakar, S.,
McDougall, S.,
Shimer, G.,
Goyal, A.,
Pietrokovski, S.,
Church, G. M.,
Daniels, C. J.,
Mao, J.,
Rice, P.,
Nölling, J.,
and Reeve, J. N.
(1997)
J. Bacteriol.
179,
7135-7155
|
| 33.
|
Kawarabayasi, Y.,
Sawada, M.,
Horikawa, H.,
Haikawa, Y.,
Hino, Y.,
Yamamoto, S.,
Sekine, M.,
Baba, S.,
Kosugi, H.,
Hosoyama, A.,
Nagai, Y.,
Sakai, M.,
Ogura, K.,
Otsuka, R.,
Nakazawa, H.,
Takamiya, M.,
Ohfuku, Y.,
Funahashi, T.,
Tanaka, T.,
Kudoh, Y.,
Yamazaki, J.,
Kushida, N.,
Oguchi, A.,
Aoki, K.,
and Kikuchi, H.
(1998)
DNA Res.
5,
147-155
|
| 34.
|
Bult, C. J.,
White, O.,
Olesen, G. J.,
Zhou, L.,
Fleischmann, R. D.,
Suttern, G. G.,
Blake, J. A.,
Fitzgerald, L. M.,
Clayton, R. A.,
Gocayne, J. D.,
Kerlavage, A. R.,
Dougherty, B. A.,
Tomb, J. F.,
Adams, M. D.,
Feich, V. I.,
Overbeek, R.,
Kirkness, E. F.,
Weinstock, K. G.,
Merrick, J. M.,
Glodek, A.,
Scott, J. L.,
Geoghagen, N. S. M.,
Weidaman, J. F.,
Fuhrmann, J. L.,
Nguyen, D.,
Utterback, T. R.,
Kelley, J. M.,
Peterson, J. D.,
Sadow, P. W.,
Hanna, M. C.,
Cotton, M. D.,
Roberts, K. M.,
Hurst, M. A.,
Kaine, B. P.,
Borodovsky, M.,
Klenk, H. P.,
Fraser, C. M.,
Smith, H. O.,
Woese, C. R.,
and Venter, J. C.
(1996)
Science
273,
1058-1073
|
| 35.
|
Blattner, F. R.,
Plunkett, G., III,
Bloch, C. A.,
Perna, N. T.,
Burland, V.,
Riley, M.,
Collado Vides, J.,
Glasner, J. D.,
Rode, C. K.,
Mayhew, G. F.,
Gregor, J.,
Davis, N. W.,
Kirkpatrick, H. A.,
Goeden, M. A.,
and Rose, D. J.
(1997)
Science
277,
1453-1474
|
| 36.
|
Dahan, D.,
Srikumar, R.,
Laprade, R.,
and Coulton, J. W.
(1996)
FEBS Lett.
392,
304-308
|
| 37.
|
Johnson, W. C., Jr.
(1990)
Proteins
7,
205-214
|
| 38.
|
Lambert, J. B.,
Shurvell, H. F.,
Lightner, D. A.,
and Cooks, R. G.
(1996)
Organic Structural Spectroscopy
, p. 295, Prentice Hall, New Jersey
|
| 39.
|
Kahn, P. C.,
and Beychok, S.
(1968)
J. Am. Chem. Soc.
90,
4168-4170
|
| 40.
|
Casey, J. P.,
and Martin, R. B.
(1972)
J. Am. Chem. Soc.
94,
6141-6151
|
| 41.
|
Liljebjelke, K.,
Adolphson, R.,
Baker, K.,
Doong, R. L.,
and Mohnen, D.
(1995)
Anal. Biochem.
225,
296-304
|
| 42.
|
Schulz, G. E.
(1992)
Curr. Opin. Struct. Biol.
2,
61-67
|
| 43.
|
Wierenga, R. K.,
Terpstra, P.,
and Hol, W. G.
(1986)
J. Mol. Biol.
187,
101-107
|
| 44.
|
Tsai, R. Y. L.,
and Reed, R. R.
(1997)
BioTechniques
23,
800-803
|
| 45.
|
Missiakas, D.,
and Raina, S.
(1997)
J. Bacteriol.
179,
2465-2471
|
| 46.
|
Chehab, F. F.,
Lim, M. E.,
and Lu, R.
(1996)
Nat. Genet.
12,
318-320
|
| 47.
|
Guisez, Y.,
Demolder, J.,
Mertens, N.,
Raeymaekers, A.,
Plaetinck, G.,
Robbens, J.,
Vandekerckhove, J.,
Remaut, E.,
and Fiers, W.
(1993)
Protein Expression Purif.
4,
240-246
|
| 48.
|
Holzinger, A.,
Phillips, K. S.,
and Weaver, T. E.
(1996)
BioTechniques
20,
804-808
|
| 49.
|
Halaas, J. L.,
Gajiwala, K. S.,
Maffei, M.,
Cohen, S. L.,
Chait, B. T.,
Rabinowitz, D.,
Lallone, R. L.,
Burley, S. K.,
and Friedman, J. M.
(1995)
Science
269,
543-546
|
| 50.
|
Ogasahara, K.,
Koike, K.,
Hamada, M.,
and Hiraoka, T.
(1976)
J. Biochem. (Tokyo)
79,
819-828
|
| 51.
|
Klatt, P.,
Schmidt, K.,
Lehner, D.,
Glatter, O.,
Bachinger, H. P.,
and Mayer, B.
(1995)
EMBO J.
14,
3687-3695
|
| 52.
| Deleted in proof
|
| 53.
| Deleted in proof
|
| 54.
|
Rossmann, M. G.,
Liljas, A.,
Branden, C.-I.,
and Banaszak, L. J.
(1975)
Enzymes
11,
61-102
|
| 55.
|
Matheron, C.,
Delort, A. M.,
Gaudet, G.,
Liptaj, T.,
and Forano, E.
(1999)
Appl. Environ. Microbiol.
65,
1941-1948
|
| 56.
|
Todaka, T.,
Yamano, S.,
and Toki, S.
(2000)
Arch. Biochem. Biophys.
374,
189-197
|
| 57.
|
Creuzenet, C.,
Bélanger, M.,
Wakarchuk, W. W.,
and Lam, J. S.
(2000)
J. Biol. Chem.
275,
19060-19067
|
| 58.
|
Kawamura, T.,
Ichihara, N.,
Sugiyama, S.,
Yokota, H.,
Ishimoto, N.,
and Ito, E.
(1985)
J. Biochem. (Tokyo)
98,
105-116
|
| 59.
|
Trivic, S.,
Leskovac, V.,
Zeremski, J.,
Stancic, B.,
and Anderson, B. M.
(1998)
J. Enzyme Inhib.
13,
57-68
|
| 60.
|
Kawamura, T.,
Ishimoto, N.,
and Ito, E.
(1982)
Methods Enzymol.
83,
519-522
|
| 61.
|
Reen, R. K.,
Jamwal, D. S.,
Taneja, S. C.,
Koul, J. L.,
Dubey, R. K.,
Wiebel, F. J.,
and Singh, J.
(1993)
Biochem. Pharmacol.
46,
229-238
|
| 62.
|
Robertson, D.,
Smith, C.,
and Bolwell, G. P.
(1996)
Biochem. J.
313,
311-317
|
| 63.
|
Pauly, H. E.,
and Pfleiderer, G.
(1975)
Hoppe-Seyler's Z. Physiol. Chem.
356,
1613-1623
|
| 64.
|
Hilt, W.,
Pfleiderer, G.,
and Frotnagel, P.
(1991)
Biochim. Biophys. Acta
1076,
298-304
|
| 65.
|
International Union of Biochemistry Nomenclature Committee.
(1979)
Enzyme Nomenclature
, p. 19, Academic Press, New York
|
| 66.
|
de Kievit, T. R.,
Dasgupta, T.,
Schweizer, H.,
and Lam, J. S.
(1995)
Mol. Microbiol.
16,
565-574
|
| 67.
|
Burrows, L. L.,
and Lam, J. S.
(1999)
J. Bacteriol.
181,
973-980
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. L. Westman, A. Preston, R. A. Field, and J. S. Lam
Biosynthesis of a Rare Di-N-Acetylated Sugar in the Lipopolysaccharides of both Pseudomonas aeruginosa and Bordetella pertussis Occurs via an Identical Scheme despite Different Gene Clusters
J. Bacteriol.,
September 15, 2008;
190(18):
6060 - 6069.
|